Australia markets open in 7 hours 18 minutes

Haemonetics Corporation (HAE)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
95.93+0.07 (+0.07%)
As of 12:40PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 4.87B
Enterprise value 5.54B
Trailing P/E 38.97
Forward P/E 22.27
PEG ratio (5-yr expected) 1.86
Price/sales (ttm)3.88
Price/book (mrq)5.16
Enterprise value/revenue 3.95
Enterprise value/EBITDA 19.05

Trading information

Stock price history

Beta (5Y monthly) 0.33
52-week change 37.51%
S&P500 52-week change 326.27%
52-week high 397.35
52-week low 370.74
50-day moving average 384.19
200-day moving average 385.03

Share statistics

Avg vol (3-month) 3472.43k
Avg vol (10-day) 3553.17k
Shares outstanding 550.79M
Implied shares outstanding 651.14M
Float 850.38M
% held by insiders 10.76%
% held by institutions 1101.33%
Shares short (30 Apr 2024) 42.62M
Short ratio (30 Apr 2024) 45.98
Short % of float (30 Apr 2024) 47.86%
Short % of shares outstanding (30 Apr 2024) 45.16%
Shares short (prior month 28 Mar 2024) 42.04M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 303 Dec 2012

Financial highlights

Fiscal year

Fiscal year ends 30 Mar 2024
Most-recent quarter (mrq)30 Mar 2024

Profitability

Profit margin 8.98%
Operating margin (ttm)10.93%

Management effectiveness

Return on assets (ttm)5.87%
Return on equity (ttm)13.22%

Income statement

Revenue (ttm)1.31B
Revenue per share (ttm)25.82
Quarterly revenue growth (yoy)12.80%
Gross profit (ttm)N/A
EBITDA 291.25M
Net income avi to common (ttm)117.56M
Diluted EPS (ttm)2.46
Quarterly earnings growth (yoy)-30.70%

Balance sheet

Total cash (mrq)178.8M
Total cash per share (mrq)3.52
Total debt (mrq)807.79M
Total debt/equity (mrq)84.15%
Current ratio (mrq)2.56
Book value per share (mrq)18.90

Cash flow statement

Operating cash flow (ttm)181.75M
Levered free cash flow (ttm)123.71M